GlassScriptPhysician profile
Kyle C Anderson
NPI 1982170676
$2,823.96
in general payments reported to CMS, 2019-2025
28 companies · $887 in 2025
The $887 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $470 · 2023: $745 · 2024: $502 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,077.05 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $567.93 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $527.09 | 2021-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $210.62 | 2022-2025 | Tezspire, Breztri, Airsupra |
| Baxter Healthcare | $176.00 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $153.40 | 2023-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $138.30 | 2021-2023 | |
| Insmed, INC. | $117.59 | 2023-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $104.97 | 2022-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.39 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Intuitive Surgical, INC. | $71.42 | 2022 | |
| Viatris Specialty LLC | $68.05 | 2025 | Yupelri |
| Gilead Sciences, INC. | $67.28 | 2022-2023 | Veklury |
| Harmony Biosciences LLC | $62.93 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Csl Behring | $52.90 | 2023 | Kcentra, Hizentra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $52.74 | 2024 | Sunosi |
| Actelion Pharmaceuticals US, INC. | $51.05 | 2022-2025 | Uptravi, Opsumit |
| Amgen INC. | $44.73 | 2024-2025 | Tezspire |
| Pfizer INC. | $32.30 | 2023-2024 | |
| Pulmonx Corporation | $28.71 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Hologic Sales and Service, LLC | $24.57 | 2025 | Aptima, Thinprep 2000 Processor |
| Mylan Specialty L.P. | $23.02 | 2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $18.54 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $17.97 | 2025 | Lumryz |
| Tactile Systems Technology INC | $17.40 | 2023 | Entre Plus, Flexitouch Plus |
| Verona Pharma, INC. | $17.35 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $17.12 | 2025 | Tyvaso |
| Phadia US INC. | $15.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.